malignant pleural effusion

From Aaushi
Jump to navigation Jump to search

Introduction

Also see pleural effusion

Etiology

Management

More general terms

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 16, 18. American College of Physicians, Philadelphia 2012, 2018.
  2. 2.0 2.1 Davies HE et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: The TIME2 randomized controlled trial. JAMA 2012 Jun 13; 307:2383. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22610520
  3. 3.0 3.1 van den Toorn LM1, Schaap E, Surmont VF Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer. 2005 Oct;50(1):123-7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15998551
  4. 4.0 4.1 4.2 Huggins JT, Doelken P, Sahn SA. Intrapleural therapy. Respirology. 2011 Aug;16(6):891-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21672085
  5. 5.0 5.1 5.2 Thomas R, Fysh ETH, Smith NA et al. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: The AMPLE randomized clinical trial. JAMA 2017 Nov 21; 318:1903. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29164255 https://jamanetwork.com/journals/jama/article-abstract/2664042?
  6. Feller-Kopman DJ, Reddy CB, DeCamp MM et al Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline. Am J Respir Crit Care Med. 2018 Oct 1;198(7):839-849 PMID: https://www.ncbi.nlm.nih.gov/pubmed/3027250
  7. Thomas JM, Musani AI. Malignant pleural effusions: a review Clin Chest Med. 2013 Sep;34(3):459-71. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23993817 Review.